Targeting B-Cell receptor signaling for anticancer therapy: the Bruton's tyrosine kinase inhibitor ibrutinib induces impressive responses in B-cell malignancies - PubMed (original) (raw)

. 2013 Jan 1;31(1):128-30.

doi: 10.1200/JCO.2012.44.4281. Epub 2012 Oct 8.

Affiliations

Targeting B-Cell receptor signaling for anticancer therapy: the Bruton's tyrosine kinase inhibitor ibrutinib induces impressive responses in B-cell malignancies

Adrian Wiestner. J Clin Oncol. 2013.

No abstract available

PubMed Disclaimer

MeSH terms

Substances

LinkOut - more resources